Letter From the Editor
Letter From the Editor: Addressing the Racial Gap in Health Care
Feature Article
Non–Clear Cell Renal Cell Carcinoma: Unpacking a Messy Term
Abstract: Non–clear cell renal cell carcinoma (nccRCC) is a heterogeneous category comprising approximately 25% of epithelial renal tumors. Unlike their far more common clear cell counterpart, […]
From Recent Issues
Feature Article
Non–Clear Cell Renal Cell Carcinoma: Unpacking a Messy Term
Abstract: Non–clear cell renal cell carcinoma (nccRCC) is a heterogeneous category comprising approximately 25% of epithelial renal tumors. Unlike their far more common clear cell counterpart, […]
Feature Article
Genetics of Prostate Cancer
Abstract: Prostate cancer is a highly heritable cancer, with contributions from rare pathogenic variants in prostate cancer predisposition genes (eg, HOXB13, BRCA2) and from common genetic […]
Feature Article
Update on PARP Inhibitors for the Treatment of Ovarian Cancer
Abstract: Poly(adenosine diphosphate-ribose) polymerase (PARP) inhibitors (PARPis) were first granted US Food and Drug Administration (FDA) approval for ovarian cancer. Trials have focused on high-grade serous […]
Supplements
Navigating the Paroxysmal Nocturnal Hemoglobinuria (PNH) Landscape
Abstract: Paroxysmal nocturnal hemoglobinuria (PNH) is a rare clonal hematopoietic stem cell disorder in which a somatic mutation in PIGA leads to reduced or absent expression of […]
The Promise of Molecular Residual Disease (MRD) Testing for Patients With Colorectal Cancer
Abstract: Molecular residual disease (MRD) assays using circulating tumor DNA (ctDNA) have the potential to detect colorectal cancer recurrence earlier than current standard-of-care surveillance techniques, such as […]
Modern Approaches in Neuroendocrine Tumors (NETs)
In the Clinic: Case Studies The following 2 patient cases highlight the clinical complexity of neuroendocrine tumors (NETs), and the widely different approaches in pancreatic NETs […]